Hyperion Therapeutics Announces Results for Phase II Study in Urea ... - FOXBusiness
2009-03-30 18:59:34

Hyperion Therapeutics Announces Results for Phase II Study in Urea ... FOXBusiness The most common adverse reactions associated with BUPHENYL(R) were amenorrhea dysfunction, decreased appetite, body odor (probably caused by its metabolite phenylacetate) and bad taste or taste aversion. Patients with urea cycle disorders should not ...